|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-9-3
|
|
pubmed:abstractText |
Blast expression of CD56 is frequent in patients with t(8;21)(q22;q22) acute myeloid leukemia and is associated with an inferior outcome. The expression of CD56 has rarely been reported in acute promyelocytic leukemia (APL) and has not been clinically characterized. Therefore, we examined the prognostic significance of CD56 expression in APL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
293-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10458245-Adult,
pubmed-meshheading:10458245-Aged,
pubmed-meshheading:10458245-Aged, 80 and over,
pubmed-meshheading:10458245-Antigens, CD56,
pubmed-meshheading:10458245-Female,
pubmed-meshheading:10458245-Humans,
pubmed-meshheading:10458245-Immunophenotyping,
pubmed-meshheading:10458245-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:10458245-Male,
pubmed-meshheading:10458245-Middle Aged,
pubmed-meshheading:10458245-Prognosis,
pubmed-meshheading:10458245-Recurrence,
pubmed-meshheading:10458245-Remission Induction,
pubmed-meshheading:10458245-Retrospective Studies,
pubmed-meshheading:10458245-Risk Factors,
pubmed-meshheading:10458245-Survival Rate,
pubmed-meshheading:10458245-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?
|
|
pubmed:affiliation |
Walter Reed Army Medical Center, Washington, DC 20307, USA.
|
|
pubmed:publicationType |
Journal Article
|
